Safety Issues. In order to ensure that both Parties are provided with an adequate opportunity to review safety matters, the Parties shall mutually agree after the Effective Date on procedures with respect to (i) regulatory reporting requirements, (ii) the review of Product labeling, (iii) maintenance of a safety database and (iv) other safety issues.
Appears in 5 contracts
Samples: Confidential Treatment (Abbott Laboratories), Collaboration Agreement (Triangle Pharmaceuticals Inc), License Agreement (Triangle Pharmaceuticals Inc)
Safety Issues. In order to ensure that both Parties are provided with an adequate opportunity to review safety matters, the Parties shall mutually agree after the Effective Date on procedures with respect to (i) regulatory reporting requirements, (ii) the review of Product labeling, (iii) maintenance of a safety database and (iv) other safety issues.. CONFIDENTIAL TREATMENT REQUESTED
Appears in 2 contracts
Samples: Development Agreement (Supergen Inc), Development Agreement (Abbott Laboratories)
